MESA RX INNOVATIONS TEAM
Alex Schmelzer spent eighteen years researching and investing in publicly traded healthcare companies for Scoggin Capital Management. He is educated in all facets of the U.S. pharmaceutical industry supply chain, including: manufacturers, branded and
generic drug distributors and retailers, pharmacy benefit managers, health insurance companies and physician practices. He is also knowledgeable in regulatory and legislative issues related to the pharmaceutical industry.
Over the greater part of the last decade, Alex has become a passionate supporter of improving the quality of our healthcare system, defining quality as reducing cost and eliminating waste.
Alex received his undergraduate degree from Yeshiva University, and an MBA from Columbia University. He lives in New York City with his wife Lisa and their two children.
Business Development Representative / Executive Assistant
Raz Haramati is an accomplished senior technologist and manager with over thirty years of experience on Wall Street. A former Senior Vice President at Lehman Brothers and independent consultant with a client list that includes major IT firms, international banks
and“Big Four” firms, Raz has built a career on working with businesses and helping identify and implement streamlining and cost-saving strategies. Since 2013, he has been the head of Business Support for Corporate Trust and Loan Agency at HSBC Bank USA, N.A.
Raz brings a unique combination of technology and analytical skills that he is now focusing on the healthcare sector.
Raz received his undergraduate degree from Yeshiva University. He lives Englewood, NJ with his wife Debbie and has four adult children.
MESA RX INNOVATIONS BOARD OF ADVISORS
Greg Arrese founded Ride Ventures, LLC in January 2016. Prior to founding Ride Ventures, Greg was an active angel investor for eight years in the technology and consumer sectors and spent 18+ years as a senior equity investment professional in the hedge fund industry.
Greg joined Scoggin Management L.P. in 2008 as a senior equity investor and was responsible for investments in the telecom, media and technology sectors until December 2015. Prior to joining Scoggin, Greg co-founded and
co- managed Iron Horse Capital Management L.P., a New York based hedge fund, from 2002 until 2008. Prior to co-founding Iron Horse Capital Management, Greg was a senior investment professional at JL Advisors, LLC, a New York based hedge fund, from 1997 until February 2002. From 1993 until 1995, Greg was a Senior Analyst at Broadview Associates L.P., an investment bank focusing on mergers and acquisitions in the technology, communications and media industries. Greg worked in the investment management group of Bankers Trust from 1992 until 1993.
Greg graduated magna cum laude from Bucknell University in 1992 with a BA in Economics and received a Masters of Business Administration from Harvard Business School in 1997. Greg is also a Chartered Financial Analyst (CFA).
Noah J. Kroloff
Noah Kroloff is a partner at late-stage healthcare venture capital firm, NGN Capital, and also Managing Partner at Black Granite Capital a growth equity firm investing in healthcare and technology. Mr. Kroloff has 25 years of experience helping innovative companies grow, primarily in healthcare. At NGN Capital, Mr. Kroloff has for the last 10 years been sourcing, evaluating, negotiating, managing and monetizing healthcare equity investments. Prior to NGN Capital, Mr. Kroloff served as an executive officer at i-STAT Corp., a publicly traded medical device company where he was Vice President for International Sales & Marketing and Corporate Development. He led the creation of global
alliances with Abbott Laboratories and Hewlett-Packard Medical Products Group and created i-STAT’s international distribution network. He was actively involved in the sale of i-STAT to Abbott for $450 million. Prior to i-STAT, Mr. Kroloff was an Engagement Manager at McKinsey & Co. where he advised leading pharmaceutical and diagnostics companies on R&D management, portfolio strategy, and alliance formation.
Mr. Kroloff received his BA in general science from Brandeis University and his MBA from the MIT Sloan School of Management where he was co-founder of and serves as a judge in the MIT $100k Entrepreneurship Competition. Mr. Kroloff is a member of the board of Valtech Cardio, Cerapedics, and Healthcare IQ and a board observer at OptiScan Biomedical and TigerText. He is a member of the board of the American Technion Society-NY and of McKinsey’s alumni advisory council and is an advisor to the NYC Economic Development Corporation’s healthcare division.
Matt Singer is the CEO of Videolicious, a global leader in employee video creation software, with millions of users, major media and Fortune 500 customers, and investors including Amazon.com. At age 24, Matt began selling products on QVC. He went on to sell more than 500,000 products through the TV shopping channel, which impressed him with its power to inform, connect, and introduce audiences to new products and ideas in a relaxed and entertaining way. Matt has also produced TV and music projects for artists such as George Clooney, James Earl Jones, Paul McCartny, Billy Joel, Ray Charles and the New York Philharmonic. He graduated summa cum laude and Phi Beta Kappa from Yale, where he received a BA in Music.